Patents by Inventor Stephen Bruce Fleming

Stephen Bruce Fleming has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190292231
    Abstract: The invention relates to polynucleotides coding for the PPVO viral genome, to fragments of the polynucleotides coding for the PPVO genome and to polynucleotides coding for individual open reading frames (ORFs) of the PPVO viral genome. The invention also relates to recombinant proteins expressed from the above mentioned polynucleotides and to fragments of said recombinant proteins, and to the use of said recombinant proteins or fragments for the preparation of pharmaceutical compositions.
    Type: Application
    Filed: June 12, 2019
    Publication date: September 26, 2019
    Applicant: AiCuris GmbH & Co. KG
    Inventors: Olaf WEBER, Sonja Maria TENNAGELS, Angela SIEGLING, Tobias SCHLAPP, Andrew Allan MERCER, Stephen Bruce FLEMING, Hans-Dieter VOLK
  • Publication number: 20170320918
    Abstract: The invention relates to polynucleotides coding for the PPVO viral genome, to fragments of the polynucleotides coding for the PPVO genome and to polynucleotides coding for individual open reading frames (ORFs) of the PPVO viral genome. The invention also relates to recombinant proteins expressed from the above mentioned polynucleotides and to fragments of said recombinant proteins, and to the use of said recombinant proteins or fragments for the preparation of pharmaceutical compositions.
    Type: Application
    Filed: July 20, 2017
    Publication date: November 9, 2017
    Applicant: AiCuris GmbH & Co. KG
    Inventors: Olaf WEBER, Sonja Maria TENNAGELS, Angela SIEGLING, Tobias SCHLAPP, Andrew Allan MERCER, Stephen Bruce FLEMING, Hans-Dieter VOLK
  • Patent number: 9714272
    Abstract: The invention relates to polynucleotides coding for the PPVO viral genome, to fragments of the polynucleotides coding for the PPVO genome and to polynucleotides coding for individual open reading frames (ORFs) of the PPVO viral genome. The invention also relates to recombinant proteins expressed from the above mentioned polynucleotides and to fragments of said recombinant proteins, and to the use of said recombinant proteins or fragments for the preparation of pharmaceutical compositions.
    Type: Grant
    Filed: September 8, 2014
    Date of Patent: July 25, 2017
    Assignee: AICURIS GMBH & CO. KG
    Inventors: Olaf Weber, Sonja Maria Tennagels, Angela Siegling, Tobias Schlapp, Andrew Allan Mercer, Stephen Bruce Fleming, Hans-Dieter Volk
  • Publication number: 20160263191
    Abstract: Viral VEGF and viral anti-inflammatory cytokine compositions, methods of treatment using them, and kits containing them for use in the promotion and/or improvement of wound healing and/or tissue repair, and for anti-scarring, anti-inflammatory, anti-fibrosis and anti-adhesion indications.
    Type: Application
    Filed: March 16, 2016
    Publication date: September 15, 2016
    Applicant: OTAGO INNOVATION LIMITED
    Inventors: Lyn Marie WISE, Stephen Bruce Fleming, Andrew Allan MERCER
  • Patent number: 9314505
    Abstract: Viral VEGF and viral anti-inflammatory cytokine compositions, methods of treatment using them, and kits containing them for use in the promotion and/or improvement of wound healing and/or tissue repair, and for anti-scarring, anti-inflammatory, anti-fibrosis and anti-adhesion indications.
    Type: Grant
    Filed: May 17, 2013
    Date of Patent: April 19, 2016
    Assignee: OTAGO INNOVATION LIMITED
    Inventors: Lyn Marie Wise, Stephen Bruce Fleming, Andrew Allan Mercer
  • Publication number: 20140377297
    Abstract: The invention relates to polynucleotides coding for the PPVO viral genome, to fragments of the polynucleotides coding for the PPVO genome and to polynucleotides coding for individual open reading frames (ORFs) of the PPVO viral genome. The invention also relates to recombinant proteins expressed from the above mentioned polynucleotides and to fragments of said recombinant proteins, and to the use of said recombinant proteins or fragments for the preparation of pharmaceutical compositions.
    Type: Application
    Filed: September 8, 2014
    Publication date: December 25, 2014
    Inventors: Olaf WEBER, Sonja Maria TENNAGELS, Angela SIEGLING, Tobias SCHLAPP, Andrew Allan MERCER, Stephen Bruce FLEMING, Hans-Dieter VOLK
  • Patent number: 8852577
    Abstract: The invention relates to polynucleotides coding for the PPVO viral genome, to fragments of the polynucleotides coding for the PPVO genome and to polynucleotides coding for individual open reading frames (ORFs) of the PPVO viral genome. The invention also relates to recombinant proteins expressed from the above mentioned polynucleotides and to fragments of said recombinant proteins, and to the use of said recombinant proteins or fragments for the preparation of pharmaceutical compositions.
    Type: Grant
    Filed: December 17, 2012
    Date of Patent: October 7, 2014
    Assignee: AiCuris GmbH & Co. KG
    Inventors: Olaf Weber, Sonja Maria Tennagels, Angela Siegling, Tobias Schlapp, Andrew Allan Mercer, Stephen Bruce Fleming, Hans-Dieter Volk
  • Publication number: 20130323201
    Abstract: Viral VEGF and viral anti-inflammatory cytokine compositions, methods of treatment using them, and kits containing them for use in the promotion and/or improvement of wound healing and/or tissue repair, and for anti-scarring, anti-inflammatory, anti-fibrosis and anti-adhesion indications.
    Type: Application
    Filed: May 17, 2013
    Publication date: December 5, 2013
    Inventors: Lyn Marie WISE, Stephen Bruce Fleming, Andrew Allan Mercer
  • Patent number: 8357363
    Abstract: The invention relates to polynucleotides coding for the PPVO viral genome, to fragments of the polynucleotides coding for the PPVO genome and to polynucleotides coding for individual open reading frames (ORFs) of the PPVO viral genome. The invention also relates to recombinant proteins expressed from the above mentioned polynucleotides and to fragments of said recombinant proteins, and to the use of said recombinant proteins or fragments for the preparation of pharmaceutical compositions.
    Type: Grant
    Filed: June 12, 2002
    Date of Patent: January 22, 2013
    Assignee: Aicuris GmbH & Co. KG
    Inventors: Olaf Weber, Sonja Maria Friederichs, Angela Siegling, Tobias Schlapp, Andrew Allan Mercer, Stephen Bruce Fleming, Hans-Dieter Volk
  • Publication number: 20040235721
    Abstract: The invention relates to polynucleotides coding for the PPVO viral genome, to fragments of the polynucleotides coding for the PPVO genome and to polynucleotides coding for individual open reading frames (ORFs) of the PPVO viral genome. The invention also relates to recombinant proteins expressed from the above mentioned polynucleotides and to fragments of said recombinant proteins, and to the use of said recombinant proteins or fragments for the preparation of pharmaceutical compositions.
    Type: Application
    Filed: June 11, 2004
    Publication date: November 25, 2004
    Inventors: Olaf Weber, Sonja Maria Friederichs, Angela Siegling, Tobias Schlapp, Andrew Allan Mercer, Stephen Bruce Fleming